ZJYL (Nasdaq: ZJYL) recently announced a significant equity restructuring plan, under which the company will implement a reverse stock split at a ratio of 20 shares consolidated into 1 share.

This decision is an important part of the company's strategic compliance measures to maintain its listing status on Nasdaq. Through equity consolidation, Zhongjin Medical aims to optimize the per-share trading price structure and enhance its image in the capital market. This initiative demonstrates the company's firm commitment to safeguarding shareholder interests and adhering to exchange regulations, while also laying a more solid capital foundation for future business expansion. The share consolidation plan is expected to be implemented soon, with specific timing to be further disclosed according to relevant regulatory requirements. The company stated it will continue to advance the compliance process, strengthen its governance structure, and promote long-term sustainable development.